Log in to save to my catalogue

Benefits of tolvaptan on early dyspnea relief in patients with acute heart failure: A meta‐analysis

Benefits of tolvaptan on early dyspnea relief in patients with acute heart failure: A meta‐analysis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9574714

Benefits of tolvaptan on early dyspnea relief in patients with acute heart failure: A meta‐analysis

About this item

Full title

Benefits of tolvaptan on early dyspnea relief in patients with acute heart failure: A meta‐analysis

Publisher

United States: John Wiley & Sons, Inc

Journal title

Clinical cardiology (Mahwah, N.J.), 2022-10, Vol.45 (10), p.995-1001

Language

English

Formats

Publication information

Publisher

United States: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Considering the prevalence of dyspnea in acute heart failure (AHF), its reduction is important to both patients and caregivers. This meta‐analysis was performed to determine the efficacy and safety of tolvaptan on early dyspnea relief in patients with AHF. A systematic search was made of PubMed, Embase, Web of Science, Cochrane Library, and clinica...

Alternative Titles

Full title

Benefits of tolvaptan on early dyspnea relief in patients with acute heart failure: A meta‐analysis

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9574714

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9574714

Other Identifiers

ISSN

0160-9289

E-ISSN

1932-8737

DOI

10.1002/clc.23889

How to access this item